ApoPharma's Ferriprox Clears ODAC Based In Part On Dosing Convenience
This article was originally published in The Pink Sheet Daily
Executive Summary
Approved thalassemia treatments are "onerous" compared to Ferriprox, which has been marketed in Europe for 12 years.